Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1M28
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $88,356
Award facts
- Contract value 100% obligated
- $88,356.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $88,356.47. This firm fixed-price delivery order, which closes on December 5, 2025, was competitively awarded with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
Dupixent (dupilumab) is a specialty pharmaceutical used to treat various allergic and inflammatory conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. As a major pharmaceutical distributor and established federal contractor, AmerisourceBergen regularly fulfills medical supply needs for the Defense Health Agency and other Department of Defense healthcare systems. This delivery order reflects the company's ongoing role as a critical vendor within the military medical supply chain and its capability to deliver specialized medications supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1M28?
SPE2DR26F1M28 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F1M28 worth?
The government has obligated $88,356 on SPE2DR26F1M28.
Is contract SPE2DR26F1M28 an order under another contract?
Yes. SPE2DR26F1M28 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1M28 competed?
The extent of competition for SPE2DR26F1M28 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award